A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Barbara Gamberi, Igor Wolfgang Blau, Miguel‐Teodoro Hernández et al.|Clinical Lymphoma Myeloma & Leukemia|2020

Cited by 2